This study is looking at how well a drug called paclitaxel works when given around the time of surgery (perioperative) for people with gastric adenocarcinoma (stomach cancer) that has spread to the lining of the abdomen (carcinomatosis) or has cancer cells found in fluid samples (positive cytology). Researchers want to see if paclitaxel, given directly into the abdomen (intraperitoneal injection), along with surgery to remove part or all of the stomach, can improve outcomes. You might also receive other medications like dexamethasone, diphenhydramine, and famotidine through a vein. The study will also look at how safe this treatment is. We are enrolling about 30 adults aged 18 and older who have a good enough physical ability (ECOG performance status ≤ 2).

Study design

This is an interventional study with a planned enrollment of 30 participants. It is a Phase II study, meaning it's an early-stage study to see if a new treatment is effective and safe.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for adverse events through study completion, which is an average of 1 year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.